No Prescription |
 |
 | ||
|
Diprosone Ointment Generic Betamethasone Dipropionate |
|
| ||
No Prescription » Prescription Drugs 6 » Diprosone Ointment Generic Betamethasone Dipropionate DIPROSONE is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. These include atopic eczema infantile eczema nummular eczema contact dermatitis neurodermatitis anogenital and senile pruritus lichen planus intertrigo and psoriasis.DIPROSONE Cream and Ointment: Apply a small amount to the affected area twice daily. For some patients adequate maintenance therapy may be achieved with once daily application.In most cases 4 weeks continuous treatment should be considered the maximum.Children: Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen. Buy Diprosone Ointment Generic Betamethasone Dipropionate and other Prescription Drugs 6 products online at Medstore. Buy Online at Medstore - Click Here!
About Diprosone Ointment Generic Betamethasone Dipropionate: Product Type: Prescription Drugs 6 Diprosone Ointment (Generic Betamethasone Dipropionate) Diprosone Ointment (Generic Betamethasone Dipropionate) Generic Betamethasone Dipropionate 0.05%w/w 15gm 50gm Generic Betamethasone Dipropionate Diprosone Ointment
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
